Clarma Capital

Clarma Capital is an Ireland-based investor with a public footprint that includes a website, LinkedIn, and active Twitter presence, but with limited public disclosure of thesis specifics, fund size, or healthcare focus. For healthcare AI founders, treat Clarma as a generalist Irish or European private capital firm whose mandate alignment is best confirmed in direct conversation. Plausible check size is $100K to $1M based on typical small private-capital economics. Stage focus is most plausibly seed and pre-seed. Founders who should approach: Irish or European seed-stage healthcare AI teams looking for a flexible local co-investor, particularly software-shaped businesses with manageable regulatory profiles, and founders raising rounds where adding a small Irish private-capital name strengthens the syndicate narrative. Founders who should not approach: regulated medical devices, biotech, US-only companies, and any team requiring a deep healthcare-specialist lead — Clarma cannot credibly anchor that journey. The realistic entry path is warm introduction through Irish operators, the Dublin and Cork startup ecosystem, or co-investors in European seed syndicates. Direct outreach via LinkedIn or their active Twitter presence is feasible given their public-facing posture. Before investing significant fundraising time, ask the introducer about Clarma’s typical check size, recent deals, and stage discipline. Treat Clarma as round-completion capital alongside a domain-specialist lead rather than as a strategic anchor for a healthcare-specific journey, and structure your fundraising calendar to confirm fit early. If after initial contact the mandate alignment is unclear, deprioritize and focus your time on investors with demonstrated thesis fit.